Attached files
| file | filename |
|---|---|
| EX-99 - EXHIBIT 99 FUNDING AGREEMENT - Epoxy, Inc. | f8k061913_ex99.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 17, 2013
Neohydro Technologies Corp.
(Exact name of registrant as specified in its charter)
Nevada | 000-53669 | N/A |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification Number) |
2200 Yarbrough Avenue, Suite B 305, El Paso TX | 79925 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (805) 857-1074
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
. Written communications pursuant to Rule 425 under the Securities Act
. Soliciting material pursuant to Rule 14a-12 under the Exchange Act
. Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
. Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Item 1.01 Entry into a Material Definitive Agreement.
On June 17, 2013, the corporation entered into a funding agreement with Craigstone, Ltd. under which Craigstone agrees to purchase $100,000 worth of newly issued common shares of the corporation at $0.03 per share within 90 days (which may be extended by consent of both parties to 120 days) and received a 2 year warrant for an additional $100,000 worth of shares at $0.03.
Exhibits
No. Exhibits
--- --------
99 Funding Agreement
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated 6/19/2013
Neohydro Technologies Corp.
By: /s/ David Gasparine
David Gasparine, President
EXHIBIT INDEX
No. Exhibits
--- --------
99 Funding Agreement